$OCGN

$0.93▲ +4.5% YTD

8 SEC 13D/G filings tracked · Last updated Oct 14, 2026

Filing History

CP $0.93▲ +4.5%Oct 14, 2026 · ThinkSabio Blog

$OCGN Ocugen: Signs OCU400 Gene Therapy Licensing Deal Worth Up to $259M in Milestones Plus 22% Royalties Across Middle East and North Africa ? • Agre…

News

OCGN ▲ +4.5% - Ocugen, Inc.

CP $0.93▲ +4.5%Oct 14, 2026 · ThinkSabio Blog

$OCGN - Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and No…

News

OCGN ▼ -0.9% - Ocugen, Inc.

CP $1.08▲ -0.9%Sep 30, 2026 · ThinkSabio Blog

$OCGN - Ocugen to Participate in Upcoming Scientific Conferences…

News

OCGN ▲ +1.0% - Ocugen, Inc.

CP $1.05▲ +1.0%Sep 29, 2026 · ThinkSabio Blog

$OCGN - Ocugen to Participate in Upcoming October Investor and Industry Conferences…

News

OCGN ▲ +2.0% - Ocugen, Inc.

CP $1.03▲ +2.0%Sep 25, 2026 · ThinkSabio Blog

$OCGN - Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU…

News

OCGN ▲ +0.8% - Ocugen, Inc.

CP $1.34▲ +0.8%Sep 1, 2026 · ThinkSabio Blog

$OCGN - Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry A…

SEC 13D/G

OCGN - Ocugen, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$1.38▼ -0.72%Aug 13, 2026 · ThinkSabio Blog

$OCGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #OCGN Ocugen, Inc. : $1.38 Sector: Healthcare | YTD: 🔽 -0.72% Th…

SEC 13D/G

$OCGN SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks Simplified

$1.20▼ -13.67%Jul 29, 2026 · ThinkSabio Blog

$OCGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #OCGN : $1.20 Sector: Healthcare | YTD: 🔽 -13.67% The SEC disclo…